Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response.

Area of Science:

• Molecular Biology
• Cancer Research
• Cellular Biology

Background:

• Mutations in breast cancer susceptibility gene 1 (BRCA1) elevate risks for breast and ovarian cancers.
• BRCA1 plays a critical role in the cellular DNA damage response pathway.

Purpose of the Study:

• To identify proteins that interact with BRCA1.
• To elucidate the role of novel interacting proteins in DNA damage response and cancer susceptibility.

Main Methods:

• Identified receptor-associated protein 80 (RAP80) as a human BRCA1-interacting protein.
• Characterized RAP80's tandem ubiquitin-interacting motif (UIM) domain for ubiquitin binding and foci formation.
• Assessed RAP80's role in recruiting BRCA1 to DNA damage sites and its function in G2/M checkpoint control.

Main Results:

• RAP80 directly binds with ubiquitin via its UIM domain.
• RAP80 facilitates the recruitment of BRCA1 to sites of DNA damage.
• RAP80 and BRCA1 collaborate in regulating the G2/M cell cycle checkpoint.

Conclusions:

• RAP80 is a novel BRCA1-interacting protein crucial for DNA damage response.
• The findings suggest a ubiquitination-dependent signaling pathway involving RAP80 and BRCA1 in DNA repair.
• This pathway is significant for maintaining genomic stability and potentially preventing cancer development.